| Online-Ressource |
Verfasst von: | Desch, Anna [VerfasserIn]  |
| Gebhardt, Christoffer [VerfasserIn]  |
| Utikal, Jochen [VerfasserIn]  |
Titel: | D-dimers in malignant melanoma |
Titelzusatz: | association with prognosis and dynamic variation in disease progress |
Verf.angabe: | Anna Desch, Christoffer Gebhardt, Jochen Utikal and Stefan W. Schneider |
Jahr: | 2017 |
Jahr des Originals: | 2016 |
Umfang: | 8 S. |
Fussnoten: | First published: 03 November 2016 ; Gesehen am 19.10.2018 |
Titel Quelle: | Enthalten in: International journal of cancer |
Ort Quelle: | Bognor Regis : Wiley-Liss, 1966 |
Jahr Quelle: | 2017 |
Band/Heft Quelle: | 140(2017), 4, Seite 914-921 |
ISSN Quelle: | 1097-0215 |
Abstract: | Malignant cells elicit a chronic hemostatic activation in disease progress. This procoagulant activity does not only bear a risk for thromboembolism but also facilitates tumor growth and dissemination. An elevated plasma D-dimer level indicates an activated coagulation and fibrinolysis. In this study, the association of D-dimer levels with clinicopathological parameters and patients outcome in melanoma was investigated analyzing in total 533 melanoma patients retrospectively. Using the cut-off point of 0.6 mg/L D-dimer 145 of the total 533 patients (27.2%) were identified with elevated plasma D-dimer levels. This increased D-dimer level positively correlated with tumor thickness (p = 0.0003), lymph node invasion (p = 0.0004) and metastatic state (p <0.0001). To assess the association of D-dimer levels with progression-free survival (PFS) and overall survival (OS), long-rank test and the Cox proportional hazard model was performed. Univariate analyses revealed that elevated D-dimer levels were significantly associated with decreased PFS (HR:2.89, 95% CI (2.07-7.56), p < 0.0001) and OS (HR:2.22, 95% CI (1.06-4.57), p = 0.035). Moreover, multivariate analyses identified elevated D-dimer levels being associated with poor disease outcome (PFS:HR:2.47, 95% CI (1.23-4.98), p = 0.012; OS:HR:2.01, 95% CI (0.09-4.45), p = 0.087). Additionally, D-dimer levels were significantly increased in terminal stage patients when comparing plasma levels 0-8 versus 24-48 weeks before death (p = 0.0003). In summary, this study presents multiple evidence that elevated D-dimer levels in melanoma patients associate with poor prognosis and therefore plasma levels of D-dimers could reveal a more aggressive phenotype of melanoma and may guide the management of anti-melanoma treatment including the concept of an anti-coagulatory therapy in tumor patients. |
DOI: | doi:10.1002/ijc.30498 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: http://dx.doi.org/10.1002/ijc.30498 |
| Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.30498 |
| DOI: https://doi.org/10.1002/ijc.30498 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | coagulation |
| D-dimer |
| melanoma |
| thrombosis |
| tumor |
K10plus-PPN: | 1582120269 |
Verknüpfungen: | → Zeitschrift |
D-dimers in malignant melanoma / Desch, Anna [VerfasserIn]; 2017 (Online-Ressource)